Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, et al: Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010, 121: 948-954.
Article
PubMed
Google Scholar
Cannon CP, Greenberg BH: Risk stratification and prognostic factors in the post-myocardial infarction patient. Am J Cardiol. 2008, 102: 13G-20G. 10.1016/j.amjcard.2008.06.006.
Article
PubMed
Google Scholar
Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, Robertson DH, Hille DA, DeLucca PT, DiBattiste PM, Demopoulos LA, Weintraub WS, Braunwald E: Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA. 2001, 286: 2405-2412. 10.1001/jama.286.19.2405.
Article
CAS
PubMed
Google Scholar
Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, MacRae AR, Jaffe AS: Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide. Clin Chem. 2007, 53: 2112-2118. 10.1373/clinchem.2007.090613.
Article
CAS
PubMed
Google Scholar
Kavsak PA, MacRae AR, Newman AM, Lustig V, Palomaki GE, Ko DT, Tu JV, Jaffe AS: Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure. Clin Biochem. 2007, 40: 326-329. 10.1016/j.clinbiochem.2006.10.025.
Article
CAS
PubMed
Google Scholar
Krishnan E, Pandya BJ, Chung L, Dabbous O: Hyperuricemia and the risk for subclinical coronary atherosclerosis-data from a prospective observational cohort study. Arthritis Res Ther. 2011, 13: R66-10.1186/ar3322.
Article
PubMed Central
PubMed
Google Scholar
Baker JF, Krishnan E, Chen L, Schumacher HR: Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?. Am J Med. 2005, 118: 816-826. 10.1016/j.amjmed.2005.03.043.
Article
CAS
PubMed
Google Scholar
Krishnan E: Gout and coronary artery disease: epidemiologic clues. Curr Rheumatol Rep. 2008, 10: 249-255. 10.1007/s11926-008-0039-0.
Article
CAS
PubMed
Google Scholar
A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA. 1980, 243: 661-669.
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G: Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004, 350: 1093-1103. 10.1056/NEJMoa035700.
Article
CAS
PubMed
Google Scholar
Gelber AC, Klag MJ, Mead LA, Thomas J, Thomas DJ, Pearson TA, Hochberg MC: Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study. Arch Intern Med. 1997, 157: 1436-1440. 10.1001/archinte.1997.00440340060005.
Article
CAS
PubMed
Google Scholar
McAdams MA, Maynard JW, Baer AN, Kottgen A, Clipp S, Coresh J, Gelber AC: Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts. J Rheumatol. 2011, 38: 135-141. 10.3899/jrheum.100418.
Article
PubMed Central
PubMed
Google Scholar
Dalbeth N, Kumar S, Stamp L, Gow P: Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. J Rheumatol. 2006, 33: 1646-1650.
CAS
PubMed
Google Scholar
Sarawate CA, Brewer KK, Yang W, Patel PA, Schumacher HR, Saag KG, Bakst AW: Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc. 2006, 81: 925-934. 10.4065/81.7.925.
Article
PubMed
Google Scholar
Brodov Y, Chouraqui P, Goldenberg I, Boyko V, Mandelzweig L, Behar S: Serum uric acid for risk stratification of patients with coronary artery disease. Cardiology. 2009, 114: 300-305. 10.1159/000239860.
Article
CAS
PubMed
Google Scholar
Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ: Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum. 2008, 58: 623-630. 10.1002/art.23121.
Article
CAS
PubMed
Google Scholar
Thanassoulis G, Brophy JM, Richard H, Pilote L: Gout, allopurinol use, and heart failure outcomes. Arch Intern Med. 2010, 170: 1358-1364. 10.1001/archinternmed.2010.198.
Article
CAS
PubMed
Google Scholar
Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA: Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009, 61: 885-892. 10.1002/art.24612.
Article
PubMed Central
PubMed
Google Scholar
Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH: Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum. 2009, 61: 225-232. 10.1002/art.24164.
Article
CAS
PubMed
Google Scholar
The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group. Circulation. 1980, 62: V79-84.
Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R: The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum. 2000, 43: 103-108. 10.1002/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C.
Article
CAS
PubMed
Google Scholar
Reyes AJ: Cardiovascular drugs and serum uric acid. Cardiovasc Drugs Ther. 2003, 17: 397-414.
Article
CAS
PubMed
Google Scholar
Krishnan E: Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout. Rheumatology (Oxford). 2010, 49: 1229-1238. 10.1093/rheumatology/keq037.
Article
CAS
Google Scholar
Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ: Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003, 41: 1287-1293. 10.1161/01.HYP.0000072820.07472.3B.
Article
CAS
PubMed
Google Scholar
Gersch C, Palii SP, Imaram W, Kim KM, Karumanchi SA, Angerhofer A, Johnson RJ, Henderson GN: Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress. Nucleosides Nucleotides Nucleic Acids. 2009, 28: 118-149. 10.1080/15257770902736400.
Article
PubMed Central
CAS
PubMed
Google Scholar
Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML: Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens. 2008, 26: 269-275. 10.1097/HJH.0b013e3282f240bf.
Article
CAS
PubMed
Google Scholar
Price KL, Sautin YY, Long DA, Zhang L, Miyazaki H, Mu W, Endou H, Johnson RJ: Human vascular smooth muscle cells express a urate transporter. J Am Soc Nephrol. 2006, 17: 1791-1795. 10.1681/ASN.2006030264.
Article
CAS
PubMed
Google Scholar
Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ: Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001, 38: 1101-1106. 10.1161/hy1101.092839.
Article
CAS
PubMed
Google Scholar
George J, Carr E, Davies J, Belch JJ, Struthers A: High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006, 114: 2508-2516. 10.1161/CIRCULATIONAHA.106.651117.
Article
CAS
PubMed
Google Scholar
Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, Rosano GM: Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol. 2004, 94: 932-935. 10.1016/j.amjcard.2004.06.032.
Article
CAS
PubMed
Google Scholar
Engberding N, Spiekermann S, Schaefer A, Heineke A, Wiencke A, Muller M, Fuchs M, Hilfiker-Kleiner D, Hornig B, Drexler H, Landmesser U: Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?. Circulation. 2004, 110: 2175-2179. 10.1161/01.CIR.0000144303.24894.1C.
Article
CAS
PubMed
Google Scholar
Guan W, Osanai T, Kamada T, Hanada H, Ishizaka H, Onodera H, Iwasa A, Fujita N, Kudo S, Ohkubo T, Okumura K: Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction. J Cardiovasc Pharmacol. 2003, 41: 699-705. 10.1097/00005344-200305000-00005.
Article
CAS
PubMed
Google Scholar
Rentoukas E, Tsarouhas K, Tsitsimpikou C, Lazaros G, Deftereos S, Vavetsi S: The prognostic impact of allopurinol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol. 2010, 145: 257-258. 10.1016/j.ijcard.2009.08.037.
Article
CAS
PubMed
Google Scholar
Tarkka MR, Vuolle M, Kaukinen S, Holm P, Eloranta J, Kaukinen U, Sisto T, Kataja J: Effect of allopurinol on myocardial oxygen free radical production in coronary bypass surgery. Scand Cardiovasc J. 2000, 34: 593-596. 10.1080/140174300750064549.
Article
CAS
PubMed
Google Scholar
Feig DI, Soletsky B, Johnson RJ: Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008, 300: 924-932. 10.1001/jama.300.8.924.
Article
PubMed Central
CAS
PubMed
Google Scholar